The second von Willebrand type A domain of cochlin has high affinity for type I, type II and type IV collagens

FEBS Letters

Volumn 582, Issue 29, 2008, Pages 4003-4007

  Nagy, Ildikó ^a   Trexler, Mária ^a   Patthy, László ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Cochlin; Collagen; Deafness; DFNA9; vWA domain

Indexed keywords

COCHLIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 4; VON WILLEBRAND FACTOR;

ARTICLE; BINDING AFFINITY; GENE MUTATION; HEARING LOSS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

CELL LINE; COCHLEA; COLLAGEN TYPE I; COLLAGEN TYPE II; COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; HEARING LOSS; HUMANS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; VON WILLEBRAND FACTOR;

EID: 56649115858     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.10.050     Document Type: Article

References (23)

1. Robertson N.G., Skvorak A.B., Yin Y., Weremowicz S., Johnson K.R., Kovatch K.A., et al. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics 46 (1997) 345-354
2. Ikezono T., Omori A., Ichinose S., Pawankar R., Watanabe A., and Yagi T. Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein. Biochim. Biophys. Acta 1535 (2001) 258-265
3. Robertson N.G., Resendes B.L., Lin J.S., Lee C., Aster J.C., Adams J.C., et al. Inner ear localization of mRNA and protein products of COCH, mutated in the sensorineural deafness and vestibular disorder, DFNA9. Hum. Mol. Genet. 10 (2001) 2493-2500
4. Kommareddi P.K., Nair T.S., Raphael Y., Telian S.A., Kim A.H., Arts H.A., et al. Cochlin isoforms and their interaction with CTL2 (SLC44A2) in the inner ear. J. Assoc. Res. Otolaryngol. 8 (2007) 435-446
5. Robertson N.G., Lu L., Heller S., Merchant S.N., Eavey R.D., McKenna M., et al. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat. Genet. 20 (1998) 299-303
6. Robertson N.G., Jones S.M., Sivakumaran T.A., Giersch A.B., Jurado S.A., Call L.M., Miller C.E., Maison S.F., Liberman M.C., and Morton C.C. A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction. Hum. Mol. Genet. 17 (2008) 3426-3434
7. Makishima T., Rodriguez C.I., Robertson N.G., Morton C.C., Stewart C.L., and Griffith A.J. Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder. Hum. Genet. 118 (2005) 29-34
8. Liepinsh E., Trexler M., Kaikkonen A., Weigelt J., Bányai L., Patthy L., et al. NMR structure of the LCCL domain and implications for DFNA9 deafness disorder. EMBO J. 20 (2001) 5347-5353
9. Khetarpal U. DFNA9 is a progressive audiovestibular dysfunction with a microfibrillar deposit in the inner ear. Laryngoscope 110 (2000) 1379-1384
10. Robertson N.G., Cremers C.W., Huygen P.L., Ikezono T., Krastins B., Kremer H., et al. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum. Mol. Genet. 15 (2006) 1071-1085
11. Grabski R., Szul T., Sasaki T., Timpl R., Mayne R., Hicks B., et al. Mutations in COCH that result in non-syndromic autosomal dominant deafness (DFNA9) affect matrix deposition of cochlin. Hum. Genet. 113 (2003) 406-416
12. Mizuta K., Ikezono T., Iwasaki S., Arai M., Hashimoto Y., Pawankar R., et al. Ultrastructural co-localization of cochlin and type II collagen in the rat semicircular canal. Neurosci. Lett. 434 (2008) 104-107
13. Trexler M., Bányai L., and Patthy L. The LCCL module. Eur. J. Biochem. 267 (2000) 5751-5757
14. Fairbanks M.B., Pollock J.R., Prairie M.D., Scahill T.A., Baczynskyj L., Heinrikson R.L., et al. Purification and structural characterization of the CD11b/CD18 integrin alpha subunit I domain reveals a folded conformation in solution. FEBS Lett. 369 (1995) 197-201
15. Hinshelwood J., and Perkins S.J. Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: a solution study by circular dichroism, fourier transform infrared and (1)H NMR spectroscopy. J. Mol. Biol. 298 (2000) 135-147
16. Huizinga E.G., Martijn van der Plas R., Kroon J., Sixma J.J., and Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure 5 (1997) 1147-1156
17. Emsley J., Cruz M., Handin R., and Liddington R. Crystal structure of the von Willebrand Factor A1 domain and implications for the binding of platelet glycoprotein Ib. J. Biol. Chem. 273 (1998) 10396-10401
18. Tuckwell D.S., Reid K.B., Barnes M.J., and Humphries M.J. The A-domain of integrin alpha 2 binds specifically to a range of collagens but is not a general receptor for the collagenous motif. Eur. J. Biochem. 241 (1996) 732-739
19. Hoylaerts M.F., Yamamoto H., Nuyts K., Vreys I., Deckmyn H., and Vermylen J. Von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem. J. 324 (1997) 185-191
20. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296 (2002) 151-155
21. Bienkowska J., Cruz M., Atiemo A., Handin R., and Liddington R. The von willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif. J. Biol. Chem. 272 (1997) 25162-25167
22. Romijn R.A., Bouma B., Wuyster W., Gros P., Kroon J., Sixma J.J., et al. Identification of the collagen-binding site of the von Willebrand factor A3-domain. J. Biol. Chem. 276 (2001) 9985-9991
23. Romijn R.A., Westein E., Bouma B., Schiphorst M.E., Sixma J.J., Lenting P.J., et al. Mapping the collagen-binding site in the von Willebrand factor-A3 domain. J. Biol. Chem. 278 (2003) 15035-15039